Resource Library
Discover Kymera’s research and resources on our exciting platform, pipeline, and additional cutting-edge technologies.
Related Resources
July 24, 2023
Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders
Gadiyar, V., Patel, G., Chen, J., Vigil, D., Ji, N., Campbell, V., Sharma, K., Shi, Y., Weiss, M., Birge, R., & Davra, V.
December 7, 2022
Proteomics enabling TPD Drug Discovery
TPD Assay Development and Screening Summit
October 25, 2022
Expression & Characterization of Novel Tissue Selective E3 Ligases
5th Annual Targeted Protein Degradation (TPD) Summit
August 15, 2022
MQAtlas Creates a Deep, Accurate and Global E3 Expression Atlas Enabling Targeted Protein Degradation Based Precision Medicine
The 14th International Symposium on Mass Spectrometry in the Health and Life Sciences
June 6, 2022
Discovery and targeted mass spectrometry-based proteomics: Enabling technologies advancing IRAK4 protein degrader along the drug discovery pipeline into the clinic
The American Society for Mass Spectrometry (ASMS) Annual Conference
April 27, 2022
Drugging Tissue Restricted E3 Ligases for TPD-based Precision Medicine
2nd Annual Ligase Targeting Drug Development Summit
April 26, 2022
Chemically Harnessing Novel E3 Ligases Biology for Next-generation TPD Therapeutics
2nd Annual Ligase Targeting Drug Development Summit
October 28, 2021
Considerations for E3 Ligase Pairing and Screening of Immune-Inflammation Targets
4th Annual TPD Summit
October 27, 2021
Understanding PK/PD for Development of STAT3 Degraders in Oncology Indications
4th Annual TPD Summit
Liquid Tumors
Solid Tumors
Read More
May 26, 2021
Drugging Tissue-Restricted E3 Ligases
Ligase Targeting Drug Development Summit